Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

NCT02334527 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class

Stopped Data from first 12 subjects-primary endpoint not met. Data analysis underway.

Conditions

Interventions

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators